Pharmacologically active boranes

Chemistry

• Borane 100%
• Lithiation 100%
• formation 100%
• Heterocyclic Compound 50%
• Antibacterial 50%
• Hydrogen Bonding 50%
• Monosaccharide 50%
• Halide 50%
• Fluorine 50%
• 1H NMR Spectroscopy 50%
• 13C NMR Spectroscopy 50%
• 19F NMR Spectroscopy 50%
• 11B NMR Spectroscopy 50%
• Boronic Acid 50%
• Phenyl Group 50%
• K 50%
• Biofilm Formation 50%
• Boron Atom 50%
• Ketones 50%
• Disaccharide 50%
• Fluorine Atom 50%
• Trimethylamine 50%
• Gas Chromatography Mass Spectrometry (GCMS) 50%
• Diborane 50%
• Structure-Activity Relationship 50%
• Minimum Inhibitory Concentration 50%
• Polysaccharide 50%
• Aldehyde 50%
• Thymidine 50%
• Serine 50%

Keyphrases

• Amines 100%
• Pharmacologically Active 100%
• Boranes 100%
• Lithiation 33%
• Oxazaborolidine 33%
• Hydrogen Bonds (H-bonds) 16%
• Gas Chromatography-mass Spectrometry 16%
• Chymotrypsin 16%
• Inhibitory Activity 16%
• Trypsin 16%
• Serine Protease 16%
• Structure-activity Relationship 16%
• Bromine 16%
• Polysaccharide 16%
• Thymidine 16%
• Streptococcus mutans (S. mutans) 16%
• Biofilm Formation 16%
• Anti-adhesion 16%
• Monosaccharides 16%
• Antibacterial Activity 16%
• Alkyl Halides 16%
• Bacterial Adhesion 16%
• Minimum Inhibitory Concentration 16%
• Disaccharides 16%
• Adhesion Formation 16%
• Bromo 16%
• Complex Formation 16%
• Proteasome Inhibition 16%
• Concentration Value 16%
• Fluorinating Agent 16%
• 13C NMR 16%
• 19F NMR 16%
• Phenyl Group 16%
• Boron Atom 16%
• Inhibition Properties 16%
• Butyl 16%
• 1H NMR Spectroscopy 16%
• Fluorine Atom 16%
• Diborane 16%
• 13C NMR Spectroscopy 16%
• Heterocyclic Rings 16%
• Trimethylamine 16%
• Enzymatic Inhibition 16%
• Bromo Derivatives 16%
• Boronic Acid Derivatives 16%
• Alkyl Aldehydes 16%
• Potassium Organotrifluoroborates 16%
• Fused Heterocycles 16%
• Reversible Competitive Inhibitor 16%
• 11B NMR Spectroscopy 16%
• Alkyl Ketones 16%